Quantbot Technologies’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Buy |
+36,152
| New | +$324K | 0.01% | 1113 |
|
|
2024
Q4 | – | Sell |
-371
| Closed | -$2.82K | – | 1481 |
|
|
2024
Q3 | $2.82K | Buy |
+371
| New | +$2.82K | ﹤0.01% | 1379 |
|
|
2024
Q2 | – | Sell |
-22,300
| Closed | -$113K | – | 1442 |
|
|
2024
Q1 | $113K | Buy |
22,300
+19,900
| +829% | +$101K | 0.01% | 1141 |
|
|
2023
Q4 | $14.4K | Sell |
2,400
-61,700
| -96% | -$370K | ﹤0.01% | 1446 |
|
|
2023
Q3 | $454K | Buy |
+64,100
| New | +$454K | 0.03% | 669 |
|
|
2023
Q2 | – | Sell |
-16,500
| Closed | -$138K | – | 1579 |
|
|
2023
Q1 | $138K | Buy |
+16,500
| New | +$138K | 0.01% | 1004 |
|
|
2021
Q4 | – | Sell |
-49,800
| Closed | -$715K | – | 1504 |
|
|
2021
Q3 | $715K | Buy |
49,800
+47,700
| +2,271% | +$685K | 0.05% | 487 |
|
|
2021
Q2 | $33K | Sell |
2,100
-13,800
| -87% | -$217K | ﹤0.01% | 1142 |
|
|
2021
Q1 | $161K | Buy |
+15,900
| New | +$161K | 0.02% | 769 |
|
|
2020
Q4 | – | Sell |
-9,400
| Closed | -$32K | – | 1294 |
|
|
2020
Q3 | $32K | Buy |
+9,400
| New | +$32K | ﹤0.01% | 932 |
|
|
2015
Q3 | – | Sell |
-6,759
| Closed | -$100K | – | 1196 |
|
|
2015
Q2 | $100K | Buy |
+6,759
| New | +$100K | 0.02% | 641 |
|
|
2014
Q4 | – | Sell |
-5,527
| Closed | -$54K | – | 1128 |
|
|
2014
Q3 | $54K | Buy |
+5,527
| New | +$54K | 0.01% | 965 |
|
|
2014
Q2 | – | Sell |
-1,000
| Closed | -$10K | – | 1168 |
|
|
2014
Q1 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 1021 |
|